AMGN Stock Quote - Amgen Inc Stock News, ResearchWarren Buffett Guru Investors

99.18 (1y: +36%)

Market Cap	72.61 B	P/E(ttm)	17.10
Enterprise Value	76.93 B	P/B	3.90

AMGN- NAS (USA)
Amgen Inc

Currently 2/5

Business Predictability Rank: 2-Star
Back Testing Results:
Average gain of all 2-Star stocks: 6% per year.
% of Stocks that are in still loss if held for 10yrs: 16%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$99.18

1 Medium Warning Sign 2 Good Signs

Bookmark

Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score

Market Cap $M	72,609	Revenue $M	17,455	Net Margin (%)	25.2	Z-Score	2.3
Enterprise Value $M	75,230	EPS $	5.9	Operating Margin %	32.3	F-Score	5
P/E(ttm))	17.1	Cash Flow Per Share $	6.7	Pre-tax Margin (%)	29.0	Higher ROA y-y	Y
Price/Book	3.9	10-y EBITDA Growth Rate %	11.6	Quick Ratio	4.4	Cash flow > Earnings	Y
Price/Sales	4.4	5-y EBITDA Growth Rate %	6.8	Current Ratio	3.9	Lower Leverage y-y	N
Price/Cash Flow	13.3	y-y EBITDA Growth Rate %	33.6	ROA % (ttm)	8.0	Higher Current Ratio y-y	Y
Dividend Yield %	1.6	Insider Buy (3m)	0	ROE % (ttm)	22.8	Less Shares Outstanding y-y	N
Payout Ratio %	26.2	Shares Outstanding M	748	ROI % (ttm)	12.3	Gross Margin Increase y-y	N

Gurus Latest Trades with AMGN

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Number of guru portfolios checked: 51.

Total Records: 103 Page: FIRST

1 2 3 4 5 6

Ticker	Guru	Date	Action	Impact	Price Range (Average)*	Current Price	Change from Average	Comment	Current Shares
AMGN	David Dreman	2007-03-31	Buy	0.93%	$55.72 - $74.25 ($66)	$ 99.18	50%	New holding, 3252231 sh.	3,252,231
AMGN	George Soros	2006-06-30	Sold Out	-0.24%	$63.94 - $71.03 ($67.7)	$ 99.18	46%	Sold Out	0
AMGN	George Soros	2006-03-31	Buy	0.24%	$71.31 - $78.1 ($74.3)	$ 99.18	34%	New holding, 90000 sh.	90,000
Real Time Picks are included for Premium Members only!!

*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

Total Records: 103 Page: FIRST

1 2 3 4 5 6

AMGN is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Ticker	Guru Name	Portfolio Date*	Current Shares	% of Shares Outstanding	% of Total Assets Managed	Change from Last Holdings
AMGN	Ray Dalio	2013-03-31	69,597	0.01	0.07	+141.68%
AMGN	Mario Gabelli	2013-03-31	22,690	0	0.02	-0.87%
AMGN	Vanguard Health Care Fund	2013-03-31	11,495,055	1.54	4.6	-2.24%
AMGN	PRIMECAP Management	2013-03-31	39,885,427	5.33	6	-5.12%
AMGN	Dodge & Cox	2013-03-31	473,372	0.06	0.06	-38.25%
AMGN	John Hussman	2013-03-31	500,000	0.07	1.9	-44.44%
AMGN	Joel Greenblatt	2013-03-31	0	0	0	Sold Out

Most recent portfolio changes are included for Premium Members only!

AMGN: Insider Buys/Sells

Click Here for All Insider Trades.

Insider	Position	Date	Trades	Shares	Trade Price ($)	Change (%)	Details
Dittrich Thomas J.W.	VP, Finance & CAO	2013-05-22	Sell	6,130	$104.78	-3.13	view
Balachandran Madhavan	EVP, Operations	2013-05-21	Sell	6,000	$103.28	-1.72	view
HENDERSON REBECCA M	Director	2013-05-17	Sell	8,421	$105.72	-3.99	view
Patton Cynthia M	SVP & CCO	2013-05-16	Sell	3,544	$105.01	-3.34	view
BIONDI FRANK	Director	2013-05-14	Sell	10,000	$108.43	-6.39	view
PELHAM JUDITH C	Director	2013-05-14	Sell	25,000	$108.25	-6.24	view
Harper Sean E	EVP, Research & Development	2013-05-02	Sell	8,000	$106.32	-4.53	view
MCNAMEE BRIAN M	SVP, Human Resources	2013-04-29	Sell	20,000	$107.5	-5.58	view
MCNAMEE BRIAN M	SVP, Human Resources	2013-04-25	Sell	15,586	$107.06	-5.19	view
BALTIMORE DAVID	Director	2013-02-28	Sell	886	$92.94	9.21	view

Press Releases about AMGN :

Amgen Statement On Government Budget Analysis For Oral-Only... 22 Feb 2013
Amgen Outlines Long-Term Strategy 07 Feb 2013
Amgen To Webcast 2013 Business Review Meeting On February 7 31 Jan 2013
The Zacks Analyst Blog Highlights: Amgen, Celgene, Gilead... 28 Jan 2013
Amgen Announces Results From Phase 3 PAVES Study Evaluating... 26 Jan 2013

Quarterly/Annual Reports about AMGN:

10-Q - AMGEN INC (0000318154) (Filer): (10-Q) 06 Nov 2012
10-Q - AMGEN INC (0000318154) (Filer): (10-Q) 08 Aug 2012
10-Q - AMGEN INC (0000318154) (Filer): (10-Q) 08 May 2012
10-Q/A - AMGEN INC (0000318154) (Filer): (10-Q/A) 14 Mar 2012
10-Q - AMGEN INC (0000318154) (Filer): (10-Q) 08 Aug 2011

News about AMGN:

Articles On GuruFocus.com

Amgen’s Dividend Policy Has Ignited Its Stock Jan 11 2013

The Best Stocks With Dividend Growth From Last Week Dec 16 2012

comment on AMGN Nov 19 2012

Why Ted Weschler Keeps Buying DaVita (DVA) Nov 09 2012

Brian Rogers’ Highest Sells: Kimberly-Clark, Pinnacle West Capital and Amgen Inc. Oct 17 2012

52-Week High Companies: AMGN, CBE, FISV, NEWS, ACE Oct 01 2012

Weekly Top Insider Sells: COF, GOOG, AMGN, CRM and FIS Sep 17 2012

Alexion is Betting on Soliris and a Little Charity Mar 06 2012

Amgen - A Good Move for Dividend Investors? Mar 02 2012

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles